Oncology Central

The advent of widely accessible lung cancer screening using low-dose computed tomography

0

On 10 November 2014, the Centers for Medicare and Medicaid Services (CMS) published a draft statement for public comment in favor of screening for lung cancer using low-dose computed tomography (LDCT). In the decision summary, CMS stated that the “evidence is sufficient to add a lung cancer screening counseling and shared decision making visit, and for appropriate beneficiaries, screening for lung cancer with LDCT, once per year, as an additional preventive service benefit under Medicare” [1].

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.